molecules of the month

“compound 60b”

RSV D486N-mut. fusion protein inh.

oral antiviral clinical candidate

from lower barrier to atropisomerism of lead

Bioorg. Med. Chem., Oct. 31, 2020

Taisho Pharmaceutical, Saitama, JP

Structure of compound 60b
1 min read

“compound 60b” (Taisho D486N mutant RSV fusion protein inhibitor clinical candidate)

request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.

already a member? log in: